Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Tamoxifen × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 53 Carcinoma, Intraductal, Noninfiltrating 7 Breast Carcinoma In Situ 5 Neoplasms 3 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Breast Neoplasms, Male 2 Triple Negative Breast Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Precancerous Conditions 1 Multiple Endocrine Neoplasia Type 1 1 Inflammatory Breast Neoplasms 1 Infertility 1 Hyperglycemia 1 Glioblastoma 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 ERα+ Breast Cancer 1 Carcinoma, Lobular 1 Breast Cancer Subjects 1 Breast Cancer Metastatic 1 Breast Cancer Female 1 Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

Cyclophosphamide 38 Dexamethasone 31 venetoclax 28 fludarabine 27 pembrolizumab 20 pomalidomide 17 Rituximab 17 Gemcitabine 16 Lenalidomide 14 Cytarabine 14 carfilzomib 11 Nivolumab 11 fludarabine phosphate 10 Temozolomide 10 Etoposide 10 Calcium Dobesilate 10 Azacitidine 10 glofitamab 9 daratumumab 9 Injections 9 obinutuzumab 8 Cisplatin 8 ibrutinib 7 cemiplimab 7 Carboplatin 7 Capecitabine 7 Bevacizumab 7 zanubrutinib 6 selinexor 6 ruxolitinib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06914674 2025-04-06

SPTP

Fudan University

Phase 2 Recruiting

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡